Encore Medical develops transcatheter septal occlusion devices to repair structural heart defects like patent foramen ovale (PFO).

PureTech Health is a publicly traded biopharmaceutical company that discovers, develops, and commercializes breakthrough medicines by founding and funding a network of subsidiary companies, including Celea Therapeutics.